Body Systems

Acute Myeloid Leukemia4 Results found

Studies recruiting participants:

Closed for recruitment:

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

The primary objective of the study is to determine whether quizartinib monotherapy prolongs overall survival (OS) compared to salvage chemotherapy in subjects with FMS-like tyrosine kinase 3 - Internal Tandem Duplication (FLT3-ITD) positive AML who are refractory to or have relapsed within 6 mont

Closed for Recruitment
Principal Investigator 
Donna E. Hogge
Body Locations and Systems 
Leukemia
Area 
Vancouver
Age 
18 and above